In addition, the deletion of Par3L leads to abnormal activation of the Lkb1/AMPK signaling cascade, leading to increased sensitivity of colon cancer cells to chemotherapy and radiotherapy (133).. This evidence concerns the gene PARD3B and malignant colon neoplasm.